Major Players Daniel Beauchamp, MD, the John Clinton Foshee Distinguished Professor of Surgery, and Ethan Lee, MD, PhD, professor of Cell & Developmental Biology and Pharmacology: high-throughput screening to identify drug-like molecules, targeting the TGF-beta and WNT pathways Jordan Berlin, MD, co-director of the GI SPORE, interim director of the Division of Hematology and Oncology, […]
Abby Shields is the program manager for Affiliations and Research Advocacy at Vanderbilt-Ingram Cancer Center. Q: What do research advocates do? A: Our advocates are a group of cancer survivors and caregivers who work alongside our researchers to ensure the research conducted at VICC is timely, relevant and serves the needs of our catchment area. […]
Katie Lang, MS, CGC, is the director of Cancer Genetic Counseling Services and the medical director of Genetic Medicine at Vanderbilt University Medical Center. Q Who should undergo genetic testing for cancer risk? A Our understanding of genetics and cancer is rapidly evolving, so this question can be tricky. But, generally speaking, we know that […]
We’re unlikely as patients to ever meet a pathologist, those doctors who, having examined samples of our blood or tissue, write reports and speak with our attending physicians about what’s fundamentally going on with our cases. When it comes to cancer treatment, how involved are these doctors? Take it from an oncologist: “The role of […]
It has been my distinct honor to serve as the director of the Vanderbilt-Ingram Cancer Center for the past 15 years. I recently announced that I am stepping down on June 30 to serve as the chief scientific and strategy officer for Vanderbilt University Medical Center and will continue to serve as Executive VUMC Vice […]
Researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy. Their report, published Nov. 1, 2021, in the journal Nature Communications, provides further evidence that TNBC […]
A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Their study, published Dec. 14, 2021, in Cell, describes findings from a single-cell transcriptomic and imaging atlas of the two most common colorectal polyps found […]
World Trade Center responders at higher risk for blood cancer-associated mutations Scientists from Vanderbilt-Ingram Cancer Center (VICC) collaborated with researchers from New York to determine that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease, according to a study published March […]
The Nashville Predators hockey team’s longtime support of Monroe Carell Jr. Children’s Hospital at Vanderbilt was on full display in November 2021. Amid Hockey Fights Cancer month, the Nashville Predators presented Children’s Hospital with the proceeds raised throughout the year from the team’s 365 Pediatric Cancer Fund presented by Twice Daily. In a masked presentation […]
With Tennessee’s only Comprehensive Cancer Center designated by the National Cancer Institute to treat people of all ages, Vanderbilt University Medical Center (VUMC) offers families a seamless care experience. The wealth of expertise at VUMC provides access to medical specialties besides hematology/ oncology and a one-stop option when families are confronted with hereditary cancer syndromes. […]
